A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

BACKGROUND: Sarcomas are a rare, heterogeneous group of tumors with variable tendencies for aggressive behavior. Molecular markers for prognosis are needed to risk stratify patients and identify those who might benefit from more intensive therapeutic strategies. PATIENTS AND METHODS: We analyzed som...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Sarcoma Res
Main Authors: Bui, Nam Q., Przybyl, Joanna, Trabucco, Sally E., Frampton, Garrett, Hastie, Trevor, van de Rijn, Matt, Ganjoo, Kristen N.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6739971/
https://ncbi.nlm.nih.gov/pubmed/31528332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-019-0122-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares